Product Data Sheet

Fmoc-Val-Ala-Gly

Catalog No. A43091

main product photo
Fmoc-Val-Ala-Gly is a cleavable linker specifically designed for antibody-drug conjugate (ADC) applications. This compound facilitates conjugation with antibodies, such as Trastuzumab, enabling the targeted delivery of cytotoxic agents to cancer cells. Its structural attributes promote effective release of the drug upon internalization, making it a valuable reagent for ADC development in cancer research.
Chemical Information
Catalog NumA43091
M. Wt467.51
FormulaC25H29N3O6
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2377585-15-2
Synonyms
SMILES
Biological Activity
DescriptionFmoc-Val-Ala-Gly is a cleavable linker specifically designed for antibody-drug conjugate (ADC) applications. This compound facilitates conjugation with antibodies, such as Trastuzumab, enabling the targeted delivery of cytotoxic agents to cancer cells. Its structural attributes promote effective release of the drug upon internalization, making it a valuable reagent for ADC development in cancer research.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.